Consistent with previous studies using ST2 knockout mice [16, 18], IL-33 neutralising antibodies [16], and soluble ST2 [17], treatment with the ST2-Fc fusion protein reduced the number of lymphocytes and neutrophils in the BAL of BLM treated mice. This evidence concerns the gene IL1RL1 and Bloom syndrome.